Anesthetic management of antiphospholipid syndrome patients who underwent cardiac surgery: three cases report.
10.4097/kjae.2014.66.2.164
- Author:
Hyunwook CHO
1
;
Yunseok JEON
;
Deok Man HONG
;
Hyun Joo KIM
;
Jeong Jin MIN
Author Information
1. Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea. jeonyunseok@gmail.com
- Publication Type:In Vitro ; Case Report
- Keywords:
Antiphospholipid syndrome;
Cardiopulmonary bypass;
Cardiac surgery
- MeSH:
Antiphospholipid Syndrome*;
Cardiopulmonary Bypass;
Heart Valve Diseases;
Humans;
Rare Diseases;
Thoracic Surgery*;
Vascular Diseases
- From:Korean Journal of Anesthesiology
2014;66(2):164-168
- CountryRepublic of Korea
- Language:English
-
Abstract:
Antiphospholipid syndrome (APS) is a rare disease in which patients display prolonged coagulation test results in vitro, but usually develop thrombotic symptoms in vivo. Patients with APS are at increased risk of valvular heart disease or coronary vascular disease, conditions that often necessitate cardiac surgery via bypass. The management of anticoagulation during cardiopulmonary bypass (CPB) is particularly challenging in these patients because of the unique features of APS. Patients with APS are constantly at risk of arterial and venous thrombotic events. Therefore it is very important to maintain proper anticoagulation perioperatively, especially during CPB. In this paper, we present three successful cases of APS patients who underwent cardiac surgery with CPB.
